CLL: Treatment Paradigm Shifts and Impact on Outcomes

Kirollos S. Hanna, PharmD, BCPS, BCOP, provides an overview of the shifts in treatments, trends, and outcomes seen over the past decade in CLL.

Now Viewing

EP: 1.CLL: Treatment Paradigm Shifts and Impact on Outcomes

EP: 2.NCCN Guidelines: Rapid Change in CLL Treatment Concepts

EP: 3.Therapy Initiation and Treatment Goals in CLL

EP: 4.Long-Term Data on the Use of BTK Inhibitors in CLL

EP: 5.Toxicity Management for BTK Inhibitors: Pharmacist’s Role

EP: 6.Head-to-Head BTK Inhibitor Data and Cardiovascular Toxicity

EP: 7.BTK Inhibitor in Combination With Anti-CD20 mAb for CLL

EP: 8.BCL2 Inhibitor in Combination With Anti-CD20 mAb for CLL

EP: 9.BTKi-Based Vs BCL2i-Based Regimens in CLL

EP: 10.Emerging Therapies in CLL

EP: 11.Advice for Optimizing Treatment Success in CLL

Related Videos

Related Content

Advertisement

February 10th 2023

Clinical Insights Into Advancements in Epithelial Ovarian Cancer Treatment

Rachel K. Anderson, PharmD, CSP

Related Content

Advertisement

February 10th 2023

Clinical Insights Into Advancements in Epithelial Ovarian Cancer Treatment

Rachel K. Anderson, PharmD, CSP